凱撒旅業(000796.SZ):擬向關聯方凱撒數科轉讓同盛品鈦保理60%股權
格隆匯6月14日丨凱撒旅業(000796.SZ)公佈,公司全資子公司凱撒同盛旅行社(集團)有限公司(“同盛旅行社”)持有天津同盛品鈦商業保理有限公司(“同盛品鈦保理”或“標的公司”)60%股權。
為進一步優化公司結構,提升資產運營效率,公司決定將同盛旅行社持有的上述股權全部轉讓給凱撒世嘉數字科技發展控股(海南)有限公司(“凱撒數科”),轉讓價格為21558.94萬元。
因凱撒數科的控股股東為凱撒世嘉旅遊文化發展集團股份有限公司(“凱撒集團”),與公司為同一控制下的企業。根據深交所《股票上市規則》的有關規定,凱撒數科為公司關聯法人,此次交易事項構成關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.